These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 30579122)

  • 1. Current scenario of artemisinin and its analogues for antimalarial activity.
    Kumari A; Karnatak M; Singh D; Shankar R; Jat JL; Sharma S; Yadav D; Shrivastava R; Verma VP
    Eur J Med Chem; 2019 Feb; 163():804-829. PubMed ID: 30579122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research.
    Patel OPS; Beteck RM; Legoabe LJ
    Eur J Med Chem; 2021 Mar; 213():113193. PubMed ID: 33508479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The birth of artemisinin.
    Ma N; Zhang Z; Liao F; Jiang T; Tu Y
    Pharmacol Ther; 2020 Dec; 216():107658. PubMed ID: 32777330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic potential of semi-synthetic artemisinin and synthetic endoperoxide antimalarial agents.
    O'Neill PM
    Expert Opin Investig Drugs; 2005 Sep; 14(9):1117-28. PubMed ID: 16144496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme as trigger and target for trioxane-containing antimalarial drugs.
    Meunier B; Robert A
    Acc Chem Res; 2010 Nov; 43(11):1444-51. PubMed ID: 20804120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artemisinin-based antimalarial research: application of biotechnology to the production of artemisinin, its mode of action, and the mechanism of resistance of Plasmodium parasites.
    Muangphrom P; Seki H; Fukushima EO; Muranaka T
    J Nat Med; 2016 Jul; 70(3):318-34. PubMed ID: 27250562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimalarial compounds: from bench to bedside.
    Olliaro PL; Taylor WR
    J Exp Biol; 2003 Nov; 206(Pt 21):3753-9. PubMed ID: 14506210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current scenario and future strategies to fight artemisinin resistance.
    Pasupureddy R; Atul ; Seshadri S; Pande V; Dixit R; Pandey KC
    Parasitol Res; 2019 Jan; 118(1):29-42. PubMed ID: 30478733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New dimensions in the field of antimalarial research against malaria resurgence.
    Narula AK; Azad CS; Nainwal LM
    Eur J Med Chem; 2019 Nov; 181():111353. PubMed ID: 31525705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria: an update on current chemotherapy.
    Visser BJ; van Vugt M; Grobusch MP
    Expert Opin Pharmacother; 2014 Oct; 15(15):2219-54. PubMed ID: 25110058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic chemistry fuels interdisciplinary approaches to the production of artemisinin.
    Corsello MA; Garg NK
    Nat Prod Rep; 2015 Mar; 32(3):359-66. PubMed ID: 25342519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current progress in the chemistry, medicinal chemistry and drug design of artemisinin based antimalarials.
    Vroman JA; Alvim-Gaston M; Avery MA
    Curr Pharm Des; 1999 Feb; 5(2):101-38. PubMed ID: 10066886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the research on the targets of anti-malaria actions of artemisinin.
    Yang J; He Y; Li Y; Zhang X; Wong YK; Shen S; Zhong T; Zhang J; Liu Q; Wang J
    Pharmacol Ther; 2020 Dec; 216():107697. PubMed ID: 33035577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antimalarial activity of 1,2,4-trioxolane/trioxane hybrids and dimers: A review.
    Fang J; Song F; Wang F
    Arch Pharm (Weinheim); 2022 Jul; 355(7):e2200077. PubMed ID: 35388499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials.
    Aratikatla EK; Kalamuddin M; Rana KC; Datta G; Asad M; Sundararaman S; Malhotra P; Mohmmed A; Bhattacharya AK
    Eur J Med Chem; 2021 Aug; 220():113454. PubMed ID: 33901900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance in malaria.
    Parija SC; Praharaj I
    Indian J Med Microbiol; 2011; 29(3):243-8. PubMed ID: 21860103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Overview of Available Antimalarials: Discovery, Mode of Action and Drug Resistance.
    Tang YQ; Ye Q; Huang H; Zheng WY
    Curr Mol Med; 2020; 20(8):583-592. PubMed ID: 32031068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Multidrug Tolerance in Plasmodium falciparum by Extended Artemisinin Pressure.
    Ménard S; Ben Haddou T; Ramadani AP; Ariey F; Iriart X; Beghain J; Bouchier C; Witkowski B; Berry A; Mercereau-Puijalon O; Benoit-Vical F
    Emerg Infect Dis; 2015 Oct; 21(10):1733-41. PubMed ID: 26401601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.